Methyl 3-(1H-pyrrolo[2,3-b]pyridin-5-yl)acrylate

Catalog No. :
ACHMZB721
CAS No. :
945029-05-0
Molecular Formula :
C11H10N2O2
Molecular Weight :
202.21

IUPAC Name:methyl (E)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)acrylate

Methyl 3-(1H-pyrrolo[2,3-b]pyridin-5-yl)acrylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1005.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(1H-pyrrolo[2,3-b]pyridin-5-yl)acrylate
IUPAC Namemethyl (E)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)acrylate
MDL No.MFCD09260185
Molecular FormulaC11H10N2O2
Molecular Weight202.21
SMILESO=C(OC)/C=C/C1=CN=C(NC=C2)C2=C1
InChI KeySWDITGRTPKJPDC-NSCUHMNNSA-N
Synonym(E)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-acrylic acid methyl ester | Methyl (E)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)acrylate | 3-(1H-Pyrrolo[2,3-b]pyridin-5-yl)-acrylic acidmethyl ester | DTXSID80640140 | methyl (E)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)prop-2-enoat
CAS No.945029-05-0
PubChem CID24229251

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHMZB721 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACINMJ295 route compound structure diagram
    ACINMJ295898746-50-4 In Stock
  4. Then
  5. ACHMZB721 route product structure diagram
    ACHMZB721945029-05-0
Inquiry

2. ACHMZB721 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRHAV016 route compound structure diagram
    ACRHAV016183208-35-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHMZB721 route product structure diagram
    ACHMZB721945029-05-0
Inquiry

Comments (0)